SEATTLE--(BUSINESS WIRE)--Athira Pharma, Inc., a clinical-stage company dedicated to developing innovative first-in-class regenerative therapies with a lead drug candidate entering Phase 2/3 clinical trials this year for Alzheimer’s disease, today announced t…